Company Filing History:
Years Active: 2016
Title: Hongsheng Tan: Innovator in Prostate Cancer Treatment
Introduction
Hongsheng Tan is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment, particularly focusing on prostate cancer. His innovative work aims to address the pressing need for new therapeutic options in this area.
Latest Patents
Hongsheng Tan holds a patent for a pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer. Prostate cancer is the most commonly diagnosed cancer in males and one of the leading causes of cancer death. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. This invention relates to a method for treating cancer that involves using an anti-cancer compound of formula (I). More particularly, it pertains to an anti-prostate cancer compound that can be isolated or chemically synthesized, showcasing specific anticancer and antitumor activity. The invention has a specific application in treating human prostate cancer.
Career Highlights
Hongsheng Tan is affiliated with Hong Kong Baptist University, where he continues to advance his research and innovation in the medical field. His work is crucial in the ongoing battle against prostate cancer, contributing to the development of effective treatment options.
Collaborations
Some of his notable coworkers include Hongxi Xu and Xin Li, who collaborate with him in his research endeavors.
Conclusion
Hongsheng Tan's contributions to prostate cancer treatment through his innovative patent highlight the importance of ongoing research in the medical field. His work not only addresses a critical health issue but also paves the way for future advancements in cancer therapy.